/RPHCF
RPHCF Stock - Rohto Pharmaceutical Co.,Ltd.
Consumer Defensive|Household & Personal ProductsOTC
$16.30+0.00%
+$0.00 (+0.00%) • Dec 19
69
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.59
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $17.93
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for RPHCF
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$16.14 – $16.46
TARGET (TP)$18.75
STOP LOSS$15.00
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.58
52W High$21.54
52W Low$14.72
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $308.63B | $270.84B | $238.66B | $199.65B | $181.05B |
| Gross Profit | $174.94B | $157.29B | $1.02B | $937.32M | $949.85M |
| Gross Margin | 56.7% | 58.1% | 0.4% | 0.5% | 0.5% |
| Operating Income | $38.94B | $40.05B | $33.96B | $29.02B | $22.99B |
| Net Income | $31.01B | $30.94B | $26.38B | $21.13B | $16.74B |
| Net Margin | 10.0% | 11.4% | 11.1% | 10.6% | 9.2% |
| EPS | $136.11 | $135.60 | $115.62 | $92.61 | $73.39 |
Company Overview
Rohto Pharmaceutical Co.,Ltd. manufactures and markets pharmaceutical products, cosmetics, and functional foods worldwide. The company provides eye care products, such as eye drops, care for contact lenses, and eye wash; and facial care products comprising face wash, lotions, and creams. It also offers medicine and medicated products for skin; medicine for internal use, such as digestive and herbal medicines; oral medicines comprising gastrointestinal medicines, herbal medicines, and supplements; non-prescription medicines; and beauty counters that provide beauty and health services. The company was formerly known as Yamada Pharmaceutical and changed its name to Rohto Pharmaceutical Co.,Ltd. in September 1949. Rohto Pharmaceutical Co.,Ltd. was founded in 1899 and is headquartered in Osaka, Japan.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
RPHCFBeat Rate
65%
Last 17 quarters
Avg Surprise
+1322.6%
EPS vs Estimate
Beats / Misses
11/6
Last 12 quarters
Latest EPS
$0.18
Q4 2025
EPS Surprise History
Q1 24
+1.4%
$0.30vs$0.29
Q2 24
-1.9%
$0.14vs$0.14
Q3 24
-6.8%
$0.23vs$0.25
Q4 24
-44.5%
$0.14vs$0.24
Q1 25
+6.1%
$0.33vs$0.31
Q2 25
+9.7%
$0.18vs$0.17
Q3 25
No data
Q4 25
+4.2%
$0.18vs$0.17
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Feb 12, 2026 | — | — | — | — |
Q4 2025 | Nov 13, 2025 | $0.17 | $0.18 | +4.2% | ✓ BEAT |
Q3 2025 | Aug 6, 2025 | — | $0.36 | — | — |
Q2 2025 | May 12, 2025 | $0.17 | $0.18 | +9.7% | ✓ BEAT |
Q1 2025 | Feb 12, 2025 | $0.31 | $0.33 | +6.1% | ✓ BEAT |
Q4 2024 | Nov 13, 2024 | $0.24 | $0.14 | -44.5% | ✗ MISS |
Q3 2024 | Aug 7, 2024 | $0.25 | $0.23 | -6.8% | ✗ MISS |
Q2 2024 | May 13, 2024 | $0.14 | $0.14 | -1.9% | ✗ MISS |
Q1 2024 | Feb 9, 2024 | $0.29 | $0.30 | +1.4% | ✓ BEAT |
Q3 2023 | Sep 30, 2023 | $0.19 | $0.22 | +13.0% | ✓ BEAT |
Q2 2023 | Jun 30, 2023 | $0.21 | $0.00 | -99.1% | ✗ MISS |
Q1 2023 | Mar 31, 2023 | $0.08 | $0.00 | -98.6% | ✗ MISS |
Q1 2023 | Feb 13, 2023 | $35.50 | $37.01 | +4.3% | ✓ BEAT |
Q4 2022 | Nov 10, 2022 | $23.01 | $27.17 | +18.1% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $0.14 | $30.66 | +22510.6% | ✓ BEAT |
Q2 2022 | May 12, 2022 | $18.85 | $17.91 | -5.0% | ✗ MISS |
Q1 2022 | Feb 10, 2022 | $19.30 | $27.08 | +40.3% | ✓ BEAT |
Q4 2021 | Nov 11, 2021 | $18.40 | $26.41 | +43.5% | ✓ BEAT |
Q3 2021 | Aug 10, 2021 | $10.96 | $20.74 | +89.2% | ✓ BEAT |
Latest News
Loading news...
Frequently Asked Questions about RPHCF
What is RPHCF's current stock price?
Rohto Pharmaceutical Co.,Ltd. (RPHCF) is currently trading at $16.30 per share. The stock has moved +0.00% today.
What is the analyst price target for RPHCF?
No analyst price targets are currently available for this stock.
What sector is Rohto Pharmaceutical Co.,Ltd. in?
Rohto Pharmaceutical Co.,Ltd. operates in the Consumer Defensive sector, specifically within the Household & Personal Products industry. The company is traded on the OTC exchange.
What is RPHCF's market cap?
Rohto Pharmaceutical Co.,Ltd. has a market capitalization of $3.68 billion, making it a mid-cap company.
Does RPHCF pay dividends?
No, Rohto Pharmaceutical Co.,Ltd. does not currently pay a dividend to shareholders.
Similar Stocks
Consumer Defensive SectorCBCFF
Calbee, Inc.
$22.22
Mkt Cap: $2.8B
CRWKF
Cranswick plc
$66.55
Mkt Cap: $3.6B
FACYF
Fancl Corporation
$17.45
Mkt Cap: $2.4B
LIOPY
Lion Corporation
$19.60
Mkt Cap: $2.7B
MRRTY
Marfrig Global Foods S.A.
$3.42
Mkt Cap: $2.9B
NSFMF
Nisshin Seifun Group Inc.
$11.50
Mkt Cap: $3.3B
NTCOY
Natura &Co Holding S.A.
$5.56
Mkt Cap: $3.8B
SOOBF
Sapporo Holdings Limited
$40.72
Mkt Cap: $3.2B
VDAHF
Vinda International Holdings Limited
$2.97
Mkt Cap: $3.6B
VDAHY
Vinda International Holdings Limited
$21.67
Mkt Cap: $3.0B
Explore stocks similar to RPHCF for comparison